Search Results - "Staal van den Brekel, A. J."

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease by Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A., Wouters, E. F.

“…BACKGROUND: An increase in resting energy expenditure (REE) commonly occurs in patients with chronic obstructive pulmonary disease (COPD), the cause of which…”
Get full text

Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients by Staal-van den Brekel, A J, Dentener, M A, Schols, A M, Buurman, W A, Wouters, E F

“…To determine whether an increased resting energy expenditure (REE) and weight loss in lung cancer patients are related to a systemic inflammatory response. REE…”
Get more information

The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment by Staal-van den Brekel, A.J., Dentener, M.A., Drent, M., ten Velde, G.P.M., Buurman, W.A., Wouters, E.F.M.

“…An inflammatory response has been observed in lung cancer both locally and systemically. The aim of the present study was to investigate whether the alveolar…”
Get full text

Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls by Staal-van den Brekel, A J, Schols, A M, Dentener, M A, ten Velde, G P, Buurman, W A, Wouters, E F

“…BACKGROUND: Weight loss is a frequently occurring problem in patients with lung cancer due to an increased resting energy expenditure (REE) and a decreased…”
Get full text

The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma by STALL-VAN DEN BREKEL, A. J, SCHOLS, A. M. W. J, DENTENER, M. A, TEN VELDE, G. P. M, BUURMAN, W. A, WOUTERS, E. F. M

“…A disturbed energy balance has been demonstrated in lung cancer patients. Both an enhanced resting energy expenditure (REE) and a decreased energy intake…”
Get full text

Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial by Billingy, Nicole E, Tromp, Vashti N M F, Aaronson, Neil K, Hoek, Rianne J A, Bogaard, Harm Jan, Onwuteaka-Philipsen, Bregje D, van de Poll-Franse, Lonneke, Hugtenburg, Jacqueline G, Belderbos, José, Becker-Commissaris, Annemarie, van den Hurk, Corina J G, Walraven, Iris

“…Previous studies using patient-reported outcomes measures (PROMs) to monitor symptoms during and after (lung) cancer treatment used alerts that were sent to…”
Get full text

Analysis of the energy balance in lung cancer patients by STAAL-VAN DEN BREKEL, A. J, SCHOLS, A. M. W. J, TEN VELDE, G. P. M, BUURMAN, W. A, WOUTERS, E. F. M

“…Previous studies have shown that an elevated resting energy expenditure (REE) frequently occurs in lung cancer patients. The aim of the present study was to…”
Get full text

Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors by Fredrix, Elisabeth W. H. M., Staal‐van den Brekel, Agnes J., Wouters, Emiel F. M.

“…BACKGROUND The purpose of this study was to investigate whether surgical removal of a tumor influences energy balance, body weight, and body composition in…”
Get full text

LBA92Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) by Burgers, S A, de Gooijer, C, Cornelissen, R, Aerts, J G, Biesma, B, Heemst, R V, Youssef-El Soud, M, Groen, H J M, Staal-van den Brekel, A J, Bootsma, G, Schijen, J H E M, Baas, P, Giovannetti, E, de Vries, J F, Hogenboom, F A, de Wit, D C M, Mahn- Schaefers, M C W, Lalezari, F, van de Noort, V, Stigt, J

“…Abstract Background All malignant mesothelioma (MM) patients progress after first-line therapy. We examined whether switch maintenance gemcitabine in patients,…”
Get full text

Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma by STAAL-VAN DEN BREKEL, A. J, THUNNISSEN, F. B. J. M, BUURMAN, W. A, WOUTERS, E. F. M

“…Vascular cell adhesion molecules (VCAM) play an important part in the regulation of inflammation and are considered to be important in the process of malignant…”
Get full text